Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Five Prime Therapeutics Inc Announces Closing Of Initial Public Offering


Monday, 23 Sep 2013 04:05pm EDT 

Five Prime Therapeutics Inc announced the closing of its initial public offering of 4,800,000 shares, resulting in aggregate gross proceeds of $62.4 million, before underwriting discounts, commissions and expenses. All of such shares were sold by Five Prime at an initial offering price of $13.00 per share. Jefferies LLC, BMO Capital Markets and Wells Fargo Securities, LLC acted as joint book-running managers and Guggenheim Securities, LLC acted as a co-manager for the offering. 

Company Quote

27.33
1.21 +4.63%
26 Dec 2014